SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001136261-15-000010
Filing Date
2015-01-16
Accepted
2015-01-16 16:29:28
Documents
1
Period of Report
2015-01-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6283
  Complete submission text file 0001136261-15-000010.txt   7827
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2555 LAKE AVE MIAMI BEACH FL 33140
Business Address
mccormack riley (Reporting) CIK: 0001536534 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 15532954